{"id":153683,"date":"2023-09-11T20:02:27","date_gmt":"2023-09-11T14:32:27","guid":{"rendered":"https:\/\/dripp.zone\/news\/?p=153683"},"modified":"2023-09-11T20:02:27","modified_gmt":"2023-09-11T14:32:27","slug":"novo-nordisk-nvo-reacted-higher-from-support-area-crypto-news","status":"publish","type":"post","link":"https:\/\/dripp.zone\/news\/novo-nordisk-nvo-reacted-higher-from-support-area-crypto-news\/","title":{"rendered":"Novo Nordisk (NVO) reacted higher from support area &#8211; Crypto News"},"content":{"rendered":"<p><\/p>\n<div id=\"fxs_article_content\">\n<p>\n                        <span class=\"fxs_socialmedia_bar_share_label\">Share:<\/span><\/p>\n<p>Novo Nordisk A\/S (NVO), a healthcare company engages in the research, development, manufacture &amp; marketing of the pharmaceutical products worldwide. It operates in two segments, Diabetes &amp; Obesity care &amp; Biopharm. It is based in Denmark, comes under Healthcare \u2013 Biotechnology sector &amp; trades as \u201cNVO\u201d ticker at NYSE.<\/p>\n<p>As mentioned in the\u00a0previous article, it favors higher in V of (I) of ((III)) &amp; expected to find support from the blue box area to resume higher as\u00a0impulse. It reacted from the blue box area as expected &amp; can see further upside in (3) of ((3)) of V. Any buyers from the blue box area, are now having risk free position.<\/p>\n<h2 class=\"fxs_headline_medium\">NVO \u2013 Elliott Wave view from 5.29.2023<\/h2>\n<p><a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/editorial.fxstreet.com\/miscelaneous\/image-638300377921005281.png\"><\/a><\/p>\n<p>It placed wave ((II)) at $30.89 low in 2016 &amp; resume higher in (I) of ((III)). It placed wave I at $58.37 high &amp; II at $41.23 low as 0.618\u00a0Fibonacci retracement. Above there, it extended higher in third\u00a0wave extension, which ended as III at $122.16 high &amp; IV at $95.02 low. Currently, it favors higher in ((3)) of V of (I) &amp; expect short term upside to continue.<\/p>\n<h2 class=\"fxs_headline_medium\">NVO \u2013 Elliott Wave latest daily view<\/h2>\n<p><a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/editorial.fxstreet.com\/miscelaneous\/image-638300378006072207.png\"><img decoding=\"async\" alt=\"Chart\" src=\"https:\/\/editorial.fxstreet.com\/miscelaneous\/image-638300378006072207.png\" \/><\/a><\/p>\n<p>In wave V, it placed ((1)) at $172.97 high, in which, it placed (1) at $144.78 high, (2) at 131.17 low, (3) at 171.70 high, (4) at 163.73 low &amp; (5) as ((1)) at 172.97 high. It was expected to find support between the blue box in $158.05 \u2013 $149.16 in which it ended ((2)) at $151.12 low. Above ((2)) low, it breaks above ((1)) high, calling for further upside in ((3)) of V. It placed (1) at $166.54 high &amp; (2) at 155.91 low. Currently, it favors higher in 5 of (3) before correcting in (4) of ((3)). It expects to remain supported in next 3, 7 or 11 swings pullback to see more upside. Alternatively, if it erases the momentum divergence in weekly, then it will be the part of III sequence in (I).<\/p>\n<h2 class=\"fxs_headline_medium\">NVO \u2013 Elliott Wave latest weekly view\u00a0<\/h2>\n<p><a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/editorial.fxstreet.com\/miscelaneous\/image-638300378086538573.png\"><img decoding=\"async\" alt=\"Chart\" src=\"https:\/\/editorial.fxstreet.com\/miscelaneous\/image-638300378086538573.png\" \/><\/a><\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Share: Novo Nordisk A\/S (NVO), a healthcare company engages in the research, development, manufacture &amp; marketing of the pharmaceutical products worldwide. It operates in two segments, Diabetes &amp; Obesity care &amp; Biopharm. It is based in Denmark, comes under Healthcare \u2013 Biotechnology sector &amp; trades as \u201cNVO\u201d ticker at NYSE. As mentioned in the\u00a0previous article, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":31451,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[173],"tags":[201,248,251,246,257,800,307,255,250,252,247,253,249,308,256,254],"class_list":["post-153683","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-others","tag-blockchain","tag-bsc","tag-chainlink","tag-coin","tag-cryptocurrency","tag-elliottwave","tag-equities","tag-gta","tag-looks-rare","tag-oracle","tag-polygon","tag-quickswap","tag-safe-moon","tag-technical-analysis","tag-wallet","tag-wordpress"],"_links":{"self":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/153683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/comments?post=153683"}],"version-history":[{"count":2,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/153683\/revisions"}],"predecessor-version":[{"id":153685,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/153683\/revisions\/153685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/media\/31451"}],"wp:attachment":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/media?parent=153683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/categories?post=153683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/tags?post=153683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}